Literature DB >> 34024154

Association of vitamins, minerals, and lead with Lipoprotein(a) in a cross-sectional cohort of US adults.

Eric J Brandt1,2, Daniel J Brandt3, Nihar R Desai4,5, Erica S Spatz4,5, Khurram Nasir6, Arya Mani4,7.   

Abstract

Lipoprotein(a)(Lp[a]) is a low-density lipoprotein-cholesterol (LDL-C)-like particle with potent pro-atherothrombotic properties. The association of Lp(a) with several circulating factors, including vitamins, remains unresolved. We performed an observational analysis using the National Health and Nutrition Examination Survey III cohort, a cohort used to monitor the nutrition status of US-citizens. We used multivariable linear regression to test associations of Lp(a) and LDL-C with levels of serum vitamins and minerals and whole-blood lead. Analyses controlled for factors known to associate with Lp(a) (age, sex, race/ethnicity, statin use, hemoglobin A1c, body mass index, hypertension, diabetes, glomerular filtration rate, alcohol intake, and saturated fat intake). LDL-C was corrected for Lp(a) mass. Multiple sensitivity tests were performed, including considering factors as categorical variables (deficient, normal, elevated). Among 7,662 subjects, Lp(a) correlated (β-coefficient) positively (change per 1 conventional unit increase) with carotenoids (lycopene (0.17(0.06,0.28), p=0.005), lutein (0.19(0.07,0.30), p=0.002), β-cryptoxanthin (0.21(0.05,0.37), p=0.01), β-carotene (0.05(0.02,0.09), p=0.003), and α-carotene (0.15(0.01,0.30), p=0.04)) and lead (0.54(0.03,1.05), p=0.04) levels when tested as continuous variables. LDL-C had similar associations. Lp(a) did not associate with vitamins A, B12, C, or E retinyl esters, folate, RBC-folate, selenium, ferritin, transferrin saturation, or calcium. With factors as categorical variables, Lp(a) but not LDL-C negatively associated with elevated vitamin B12 (-5.41(-9.50, -1.53), p=0.01) and folate (-2.86(-5.09, -0.63), p=0.01). In conclusion, Lp(a) associated similarly to LDL-C when vitamins, minerals, and lead were tested as continuous variables, while only Lp(a) correlated with vitamin B12 and folate when tested as categorical variables. These observations are hypotheses generating and require further studies to determine causality.

Entities:  

Keywords:  LDL cholesterol; Lipoprotein(a); lead; minerals; vitamins

Year:  2021        PMID: 34024154      PMCID: PMC8964024          DOI: 10.1024/0300-9831/a000709

Source DB:  PubMed          Journal:  Int J Vitam Nutr Res        ISSN: 0300-9831            Impact factor:   1.784


  49 in total

1.  Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans.

Authors:  S M Marcovina; J J Albers; E Wijsman; Z Zhang; N H Chapman; H Kennedy
Journal:  J Lipid Res       Date:  1996-12       Impact factor: 5.922

Review 2.  A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies.

Authors:  Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2017-02-14       Impact factor: 24.094

3.  Effects of lead and mercury on the blood proteome of children.

Authors:  Robert E Birdsall; Michael P Kiley; Zaneer M Segu; Christopher D Palmer; Milan Madera; Brooks B Gump; James A MacKenzie; Patrick J Parsons; Yehia Mechref; Milos V Novotny; Kestutis G Bendinskas
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

4.  Dose-related increase of HDL-cholesterol levels after N-acetylcysteine in man.

Authors:  G Franceschini; J P Werba; O Safa; I Gikalov; C R Sirtori
Journal:  Pharmacol Res       Date:  1993 Oct-Nov       Impact factor: 7.658

5.  Prevalence of Elevated Lp(a) Mass Levels and Patient Thresholds in 532 359 Patients in the United States.

Authors:  Steve Varvel; Joseph P McConnell; Sotirios Tsimikas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09-22       Impact factor: 8.311

6.  Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study.

Authors:  S M Haffner; K K Gruber; P A Morales; H P Hazuda; R A Valdez; B D Mitchell; M P Stern
Journal:  Am J Epidemiol       Date:  1992-11-01       Impact factor: 4.897

7.  Oxidative modification of lipoprotein(a) and the effect of beta-carotene.

Authors:  M Naruszewicz; E Selinger; J Davignon
Journal:  Metabolism       Date:  1992-11       Impact factor: 8.694

8.  Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.

Authors:  Deepak P Vivekananthan; Marc S Penn; Shelly K Sapp; Amy Hsu; Eric J Topol
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

Review 9.  Lipoprotein (a): impact by ethnicity and environmental and medical conditions.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Lars Berglund
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

10.  Lipoprotein(a) as a cardiovascular risk factor: current status.

Authors:  Børge G Nordestgaard; M John Chapman; Kausik Ray; Jan Borén; Felicita Andreotti; Gerald F Watts; Henry Ginsberg; Pierre Amarenco; Alberico Catapano; Olivier S Descamps; Edward Fisher; Petri T Kovanen; Jan Albert Kuivenhoven; Philippe Lesnik; Luis Masana; Zeljko Reiner; Marja-Riitta Taskinen; Lale Tokgözoglu; Anne Tybjærg-Hansen
Journal:  Eur Heart J       Date:  2010-10-21       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.